Please click here to see the latest news stories relating to Covid-19

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your organisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Oligonucleotides are potential drug candidates and often prepared via phosphoramidite method. TCI offers a variety of Reagents used in this method.

We explore some of the key functionalities within Torx™ that make it an effective CRO management solution.

Explore how Torx Make can facilitate the tracking and management of any project compound in seconds, allowing drug discovery teams to connect and share information without the need for resou...

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities

Our Valued Sponsors & Partners